BridgeMD
New treatment option for Anxiety and Fear
Official title Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery
ClinicalTrials.gov ID: NCT06917300
What this study is testing
- What it's testing
- The aim of this research study is to evaluate the impact of immersive VR exposure on preoperative anxiety and pain. Additionally, to assess whether VR intervention would significantly alleviate pain and anxiety levels of patients undergoing complex spinal surgeries.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 70
You may be able to join if
- Adult patients between 25-70 years old, undergoing an elective spinal surgery.
- Patient's admission prior to surgery day (at least 1 day).
- Expected hospital stay - 2 days.
- Capable of providing informed consent and participate in the study follow-up questionnaire.
- Patients speak Polish.
You likely can't join if
- Congestive heart failure, hypertension and anti-hypertensive medications
- Adrenal insufficiency
- Alcohol addiction (evaluated by CAGE/AUDIT) and substance addiction (evaluated by DUDIT)
- Cognitive impairment (evaluated by MMSE, MoCA)
- Cerebrovascular diseases, ophthalmological diseases (strabismus, diplopia, retina degeneration, glaucoma), neurological conditions (epilepsy or...
- Auditory impairment
See the full eligibility criteria
- Adult patients between 25-70 years old, undergoing an elective spinal surgery.
- Patient's admission prior to surgery day (at least 1 day).
- Expected hospital stay - 2 days.
- Capable of providing informed consent and participate in the study follow-up questionnaire.
- Patients speak Polish.
- Congestive heart failure, hypertension and anti-hypertensive medications
- Adrenal insufficiency
- Alcohol addiction (evaluated by CAGE/AUDIT) and substance addiction (evaluated by DUDIT)
- Cognitive impairment (evaluated by MMSE, MoCA)
- Cerebrovascular diseases, ophthalmological diseases (strabismus, diplopia, retina degeneration, glaucoma), neurological conditions (epilepsy or seizure, dementia, vertigo, dizziness, motion sickness) - evaluated by...
- Auditory impairment
- Psychiatric illness (schizophrenia, bipolar disorder, psychotic depression) - (evaluated by MINI questionnaire)
- Patients with neuropathic pain
- Use of sedative drugs, anti-depressants, anxiolytics, and anti-epileptic drugs
- Intracranial functional lesions (patients after TBI (Traumatic Brain Injury), cognitive or executive dysfunction)
- Patient with high risk due to major and emergency operations
- Claustrophobia
- GCS \< 15
The study team makes the final eligibility decision.
Where it's taking place
- Lodz, Łódź Voivodeship, Poland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lodz, Łódź Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.